Hiruvim_ - FACEIT level 10, 2,282 ELO

Russia
On FACEIT since 2026 194 matches tracked 128 matches in 30 days
ELO ▲ 146
2,282
30-day peak: 2,454
Rank EU
#105,497
Russia #29,925 in Russia
Last updated:

Hiruvim_ at a glance

Level 10 2,282 ELO best map Nuke (67%)
2,250-2,499 ELO

Last 20 matches compared with 2,986 players in this group: K/R, ADR and win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 3%
0.82
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.34 ConsistencyShare of matches with a rating of 0.90 or higher. 30%
K/R
0.58
better than 2% of players
2,250-2,499 ELO avg: 0.74
Last 12 months
ADR
67.0
better than 3% of players
2,250-2,499 ELO avg: 80.7
Last 12 months
Win rate
40%
better than 15% of players
2,250-2,499 ELO avg: 50%
Last 12 months

Facts

172 ELO Next goal ELO to the peak (2,454)
3 Comebacks last 90 days
3 W · 2 L Overtime in overtime
Mirage Favorite map 74 of 194 matches
Nuke 67% Map pool tip weakest: Ancient 46%
4 knife kills Rare kills last 90 days
On Saturdays Best time 60% win rate vs. 51%
FormMapsTiming

172 ELO away from the recorded peak (2,454). 3 wins after trailing at halftime (last 90 days). 5 matches in overtime, 3 of them won (last 90 days). Most played: Mirage (74 of 194 matches). Strongest map: Nuke (67% win rate, 15 matches). Weakest: Ancient (46%, 24 matches). 4 knife kills (last 90 days). Best results on Saturdays: 60% win rate vs. 51% overall (47 matches).

About Hiruvim_

Hiruvim_ plays CS2 on FACEIT level 10 with 2,282 ELO. The stats cover 194 matches. The strongest map is Nuke with a 67% win rate in 15 matches. Most played: Mirage with 74 matches and a 54% win rate. Biggest strength: Clutch 1v1 won at 49%, better than 93% of level 10 · 2,250-2,499 ELO players. Hiruvim_ won 3 matches after trailing at halftime (last 90 days). Last 20 matches: 8 wins, 12 losses, -25 ELO. Hiruvim_ does best on Saturdays: 60% win rate in 47 matches.